DOI QR코드

DOI QR Code

Assessing the Blood Supply Status of the Focal Ground-Glass Opacity in Lungs Using Spectral Computed Tomography

  • Liu, Guanfu (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Li, Mengying (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Li, Guosheng (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Li, Zhiyong (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Liu, Ailian (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Pu, Renwang (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Cao, Huizhi (Department of Radiology, First Affiliated Hospital of Dalian Medical University) ;
  • Liu, Yijun (Department of Radiology, First Affiliated Hospital of Dalian Medical University)
  • Received : 2016.12.28
  • Accepted : 2017.07.01
  • Published : 2018.02.01

Abstract

Objective: To exploit material decomposition analysis in dual-energy spectral computed tomography (CT) to assess the blood supply status of the ground-glass opacity (GGO) in lungs. Materials and Methods: This retrospective study included 48 patients with lung adenocarcinoma, who underwent a contrast-enhanced dual-energy spectral CT scan before treatment (53 GGOs in total). The iodine concentration (IC) and water content (WC) of the GGO, the contralateral and ipsilateral normal lung tissues were measured in the arterial phase (AP) and their differences were analyzed. IC, normalized IC (NIC), and WC values were compared between the pure ground-glass opacity (pGGO) and the mixed ground-glass opacity (mGGO), and between the group of preinvasive lesions and the minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IA) groups. Results: The values of pGGO ($IC=20.9{\pm}6.2mg/mL$ and $WC=345.1{\pm}87.1mg/mL$) and mGGO ($IC=23.8{\pm}8.3mg/mL$ and $WC=606.8{\pm}124.5mg/mL$) in the AP were significantly higher than those of the contralateral normal lung tissues ($IC=15.0{\pm}4.9mg/mL$ and $WC=156.4{\pm}36.8mg/mL$; $IC=16.2{\pm}5.7mg/mL$ and $WC=169.4{\pm}41.0mg/mL$) and ipsilateral normal lung tissues ($IC=15.1{\pm}6.2mg/mL$ and $WC=156.3{\pm}38.8mg/mL$; $IC=15.9{\pm}6.0mg/mL$ and $WC=174.7{\pm}39.2mg/mL$; all p < 0.001). After normalizing the data according to the values of the artery, pGGO (NIC = 0.1 and $WC=345.1{\pm}87.1mg/mL$) and mGGO (NIC = 0.2 and $WC=606.8{\pm}124.5mg/mL$) were statistically different (p = 0.049 and p < 0.001, respectively), but not for the IC value (p = 0.161). The WC values of the group with preinvasive lesions and MIA ($345.4{\pm}96.1mg/mL$) and IA ($550.1{\pm}158.2mg/mL$) were statistically different (p < 0.001). Conclusion: Using dual-energy spectral CT and material decomposition analysis, the IC in GGO can be quantitatively measured which can be an indicator of the blood supply status in the GGO.

Keywords

References

  1. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS; ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. Am J Roentgenol 2002;178:1053-1057 https://doi.org/10.2214/ajr.178.5.1781053
  2. Sudo N, Nambu A, Yamakawa T, Kawamoto M, Fujino S, Watanabe M, et al. Pulmonary focal fibrosis associated with microscopic arterio-venous fistula manifesting as focal ground-glass opacity on thin-section CT. BMC Pulm Med 2013;13:3 https://doi.org/10.1186/1471-2466-13-3
  3. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285 https://doi.org/10.1097/JTO.0b013e318206a221
  4. Eguchi T, Kondo R, Kawakami S, Matsushita M, Yoshizawa A, Hara D, et al. Computed tomography attenuation predicts the growth of pure ground-glass nodules. Lung Cancer 2014;84:242-247 https://doi.org/10.1016/j.lungcan.2014.03.009
  5. Matsuguma H, Oki I, Nakahara R, Suzuki H, Kasai T, Kamiyama Y, et al. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2013;95:1878-1884 https://doi.org/10.1016/j.athoracsur.2013.02.022
  6. Maeyashiki T, Suzuki K, Hattori A, Matsunaga T, Takamochi K, Oh S. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur J Cardiothorac Surg 2013;43:915-918 https://doi.org/10.1093/ejcts/ezs516
  7. Murakawa T, Konoeda C, Ito T, Inoue Y, Sano A, Nagayama K, et al. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Eur J Cardiothorac Surg 2013;43:925-932 https://doi.org/10.1093/ejcts/ezs467
  8. Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013;268:265-273 https://doi.org/10.1148/radiol.13120949
  9. Eguchi T, Yoshizawa A, Kawakami S, Kumeda H, Umesaki T, Agatsuma H, et al. Tumor size and computed tomography attenuation of pulmonary pure ground-glass nodules are useful for predicting pathological invasiveness. PLoS One 2014;9:e97867 https://doi.org/10.1371/journal.pone.0097867
  10. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-1259 https://doi.org/10.1259/bjr.73.876.11205667
  11. Chang B, Hwang JH, Choi YH, Chung MP, Kim H, Kwon OJ, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013;143:172-178 https://doi.org/10.1378/chest.11-2501
  12. Cho S, Yang H, Kim K, Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg 2013;96:1190-1195 https://doi.org/10.1016/j.athoracsur.2013.05.062
  13. Lee SW, Leem CS, Kim TJ, Lee KW, Chung JH, Jheon S, et al. The long-term course of ground-glass opacities detected on thin-section computed tomography. Respir Med 2013;107:904-910 https://doi.org/10.1016/j.rmed.2013.02.014
  14. Tsunezuka Y, Shimizu Y, Tanaka N, Takayanagi T, Kawano M. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. World J Surg 2007;31:314-317 https://doi.org/10.1007/s00268-006-0475-9
  15. Uehara H, Tsutani Y, Okumura S, Nakayama H, Adachi S, Yoshimura M, et al. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma. Ann Thorac Surg 2013;96:1958-1965 https://doi.org/10.1016/j.athoracsur.2013.06.086
  16. Yuan X, Zhang J, Quan C, Cao J, Ao G, Tian Y, et al. Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT. Eur Radiol 2013;23:2469-2474 https://doi.org/10.1007/s00330-013-2842-x
  17. Shi J, Schmid-Bindert G, Fink C, Sudarski S, Apfaltrer P, Pilz LR, et al. Dynamic volume perfusion CT in patients with lung cancer: baseline perfusion characteristics of different histological subtypes. Eur J Radiol 2013;82:e894-e900 https://doi.org/10.1016/j.ejrad.2013.08.023
  18. Johnson TR, Krauss B, Sedlmair M, Grasruck M, Bruder H, Morhard D, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol 2007;17:1510-1517 https://doi.org/10.1007/s00330-006-0517-6
  19. Chae EJ, Song JW, Krauss B, Song KS, Lee CW, Lee HJ, et al. Dual-energy computed tomography characterization of solitary pulmonary nodules. J Thorac Imaging 2010;25:301-310 https://doi.org/10.1097/RTI.0b013e3181e16232
  20. Chae EJ, Song JW, Seo JB, Krauss B, Jang YM, Song KS. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience. Radiology 2008;249:671-681 https://doi.org/10.1148/radiol.2492071956
  21. Kawai T, Shibamoto Y, Hara M, Arakawa T, Nagai K, Ohashi K. Can dual-energy CT evaluate contrast enhancement of groundglass attenuation? Phantom and preliminary clinical studies. Acad Radiol 2011;18:682-689 https://doi.org/10.1016/j.acra.2010.12.014
  22. Lee HJ, Goo JM, Lee CH, Yoo CG, Kim YT, Im JG. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol 2007;8:22-31 https://doi.org/10.3348/kjr.2007.8.1.22
  23. Thieme SF, Johnson TR, Lee C, McWilliams J, Becker CR, Reiser MF, et al. Dual-energy CT for the assessment of contrast material distribution in the pulmonary parenchyma. Am J Roentgenol 2009;193:144-149 https://doi.org/10.2214/AJR.08.1653
  24. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-698 https://doi.org/10.1148/radiology.189.3.8234692
  25. Yang ZG, Sone S, Takashima S, Li F, Honda T, Maruyama Y, et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. Am J Roentgenol 2001;176:1399-1407 https://doi.org/10.2214/ajr.176.6.1761399
  26. Aoki M, Takai Y, Narita Y, Hirose K, Sato M, Akimoto H, et al. Correlation between tumor size and blood volume in lung tumors: a prospective study on dual-energy gemstone spectral CT imaging. J Radiat Res 2014;55:917-923 https://doi.org/10.1093/jrr/rru026

Cited by

  1. Spectral CT Analysis of Solitary Pulmonary Nodules for Differentiating Malignancy from Benignancy: The Value of Iodine Concentration Spatial Distribution Difference vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/4830659
  2. A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology vol.20, pp.12, 2019, https://doi.org/10.3348/kjr.2019.0928
  3. Invasive Pulmonary Adenocarcinomas Versus Preinvasive Lesions Appearing as Pure Ground-Glass Nodules: Differentiation Using Enhanced Dual-Source Dual-Energy CT vol.213, pp.3, 2018, https://doi.org/10.2214/ajr.19.21245
  4. Application of Dual-Energy Spectral Computed Tomography to Thoracic Oncology Imaging vol.21, pp.7, 2018, https://doi.org/10.3348/kjr.2019.0711
  5. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review vol.2020, pp.None, 2018, https://doi.org/10.1155/2020/8825761
  6. Medical adhesive vs hookwire for computed tomography-guided preoperative localization and risk factors of major complications vol.94, pp.1125, 2018, https://doi.org/10.1259/bjr.20201208